Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ionis
Pharma
Arrowhead data set up Redemplo for hypertriglyceridemia nod
Arrowhead has reported data from two phase 3 trials that could set the company up for Redemplo to gain approval to treat severe hypertriglyceridemia.
Kevin Dunleavy
Jul 22, 2026 10:52am
AstraZeneca, Ionis shares slide with ATTR-CM trial failure
Jul 9, 2026 11:36am
FDA approves transformational expansion of Ionis’ Tryngolza
Jun 25, 2026 8:13am
As questions swirl, Alnylam eyes ATTR market leadership by 2030
Mar 26, 2026 2:08pm
JPM26, Day 2: Novo CEO talks 'mastering' cash pay sales in '26
Jan 13, 2026 7:29pm
Ionis doubles its sales projection for Tryngolza in sHTG to $2B
Jan 13, 2026 3:45pm
